This oversubscribed Series A funding round was led by General Catalyst with additional investment from new investors, British ...

In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...

(Reuters) -Drugmaker AstraZeneca said on Monday it will buy biotechnology firm EsoBiotec for up to $1 billion. EsoBiotec's ...

Acquisition includes EsoBiotec’s world-leading in vivo delivery platform with potential to transform cell therapyMONT-SAINT-GUIBERT, Belgium, March 17, 2025 (GLOBE NEWSWIRE) -- EsoBiotec SA, a ...

The high-profile stockpicker is the eye disorder treatment hopeful’s biggest shareholder. Ahead of the results of a crucial ...

Barrington Research issued their Q1 2026 earnings estimates for shares of Anika Therapeutics in a research report issued on Thursday, March 13th. Barrington Research analyst M. Petusky expects that ...

William Blair cut their Q1 2025 earnings per share (EPS) estimates for Arcturus Therapeutics in a report issued on Thursday, March 13th. William Blair analyst M. Minter now forecasts that the ...

Colossal Biosciences, a Dallas-based biotechnology and genetic engineering startup valued at $10 billion, has raised $435 ...

A biotechnology company whose goal is to bring back the wooly mammoth says its recent small step is big news. Colossal ...

In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech ...

Additionally, Unity Biotechnology also announced 3 Yehia Hashad, MD, executive vice president of research and development and ...

UD researchers discover that differences in gene expression in fat could be the key to targeted obesity treatment. According ...